FDA inspection
Jiangxi Tianxin Pharmaceutical Co., Ltd.: FDA inspection ending Jul 19, 2024
FDA inspection 1247725 · Voluntary Action Indicated (VAI) · Leping
Key facts
| Inspection ID | 1247725 |
|---|---|
| Firm | Jiangxi Tianxin Pharmaceutical Co., Ltd. |
| FEI number | 3006661959 |
| Address | Leanjiang Industrial Park |
| City | Leping |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Jul 19, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data